3,4-methylenedioxyethamphetamine has been researched along with Sensitivity and Specificity in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (50.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| da Costa, JL; da Matta Chasin, AA | 1 |
| de Boeck, G; Kraemer, T; Lamers, CT; Maurer, HH; Peters, FT; Riedel, WJ; Samyn, N | 1 |
| Abraham, TT; Huestis, MA; Pirnay, SO | 1 |
| Kauert, G; Röhrich, J | 1 |
| Sadeghipour, F; Veuthey, JL | 1 |
| Dirnhofer, R; Keller, T; Miki, A; Regenscheit, P; Schneider, A; Tsuchihashi, H | 1 |
| Cody, JT; Hensley, D | 1 |
| Krogh, M; Rasmussen, KE; Ugland, HG | 1 |
| Clauwaert, KM; De Leenheer, AP; De Letter, EA; Lambert, WE; Van Bocxlaer, JF; Van Calenbergh, S | 1 |
| Brunnenberg, M; Kovar, KA | 1 |
10 other study(ies) available for 3,4-methylenedioxyethamphetamine and Sensitivity and Specificity
| Article | Year |
|---|---|
Determination of MDMA, MDEA and MDA in urine by high performance liquid chromatography with fluorescence detection.
Topics: 3,4-Methylenedioxyamphetamine; Chromatography, High Pressure Liquid; Forensic Medicine; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence | 2004 |
Drug testing in blood: validated negative-ion chemical ionization gas chromatographic-mass spectrometric assay for enantioselective measurement of the designer drugs MDEA, MDMA, and MDA and its application to samples from a controlled study with MDMA.
Topics: 3,4-Methylenedioxyamphetamine; Dose-Response Relationship, Drug; Gas Chromatography-Mass Spectrometry; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Sensitivity and Specificity; Stereoisomerism; Substance Abuse Detection; Time Factors | 2005 |
Sensitive gas chromatography-mass spectrometry method for simultaneous measurement of MDEA, MDMA, and metabolites HMA, MDA, and HMMA in human urine.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Calibration; Central Nervous System Stimulants; Dopamine; Gas Chromatography-Mass Spectrometry; Humans; Hydrolysis; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Sensitivity and Specificity; Substance Abuse Detection | 2006 |
Concentrations of delta 9-tetrahydrocannabinol, cocaine and 6-monoacetylmorphine in hair of drug abusers.
Topics: 3,4-Methylenedioxyamphetamine; Accidents, Traffic; Amphetamine; Cocaine; Crime; Designer Drugs; Dronabinol; Expert Testimony; Gas Chromatography-Mass Spectrometry; Hair; Heroin Dependence; Humans; Illicit Drugs; Marijuana Abuse; Morphine Derivatives; N-Methyl-3,4-methylenedioxyamphetamine; Opioid-Related Disorders; Psychotropic Drugs; Sensitivity and Specificity | 1996 |
Sensitive and selective determination of methylenedioxylated amphetamines by high-performance liquid chromatography with fluorimetric detection.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Chromatography, High Pressure Liquid; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Substance Abuse Detection; Tablets | 1997 |
Detection of designer drugs in human hair by ion mobility spectrometry (IMS).
Topics: 3,4-Methylenedioxyamphetamine; Designer Drugs; Forensic Medicine; Hair; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Sensitivity and Specificity; Spectrometry, Mass, Secondary Ion; Substance-Related Disorders | 1998 |
Simultaneous determination of amphetamine, methamphetamine, methylenedioxyamphetamine (MDA), methylenedioxymethamphetamine (MDMA), and methylenedioxyethylamphetamine (MDEA) enantiomers by GC-MS.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Central Nervous System Stimulants; Gas Chromatography-Mass Spectrometry; Humans; In Vitro Techniques; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Sensitivity and Specificity; Stereoisomerism; Substance Abuse Detection; Time Factors; Urine | 1999 |
Automated determination of 'Ecstasy' and amphetamines in urine by SPME and capillary gas chromatography after propylchloroformate derivatisation.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Designer Drugs; Esters; Evaluation Studies as Topic; Formates; Gas Chromatography-Mass Spectrometry; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Sensitivity and Specificity; Substance Abuse Detection | 1999 |
Determination of the designer drugs 3, 4-methylenedioxymethamphetamine, 3,4-methylenedioxyethylamphetamine, and 3,4-methylenedioxyamphetamine with HPLC and fluorescence detection in whole blood, serum, vitreous humor, and urine.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Chromatography, High Pressure Liquid; Designer Drugs; Humans; Mass Spectrometry; N-Methyl-3,4-methylenedioxyamphetamine; Rabbits; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence; Substance Abuse Detection; Vitreous Body | 2000 |
Stereospecific analysis of ecstasy-like N-ethyl-3,4-methylenedioxyamphetamine and its metabolites in humans.
Topics: 3,4-Methylenedioxyamphetamine; Chromatography, High Pressure Liquid; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Sensitivity and Specificity | 2001 |